Measurements of the t(t)Overbar charge asymmetry using the dilepton decay channel in pp collisions at root s=7 TeV

The tt¯ charge asymmetry in proton-proton collisions at s√ = 7 TeV is measured using the dilepton decay channel (ee, e μ , or μμ ). The data correspond to a total integrated luminosity of 5.0 fb −1 , collected by the CMS experiment at the LHC. The tt and lepton charge asymmetries, defined as the differences in absolute values of the rapidities between the reconstructed top quarks and antiquarks and of the pseudorapidities between the positive and negative leptons, respectively, are measured to be A C = −0 . 010 ± 0 . 017 (stat . ) ± 0 . 008 (syst . ) and AlepC = 0 . 009 ± 0 . 010 (stat . ) ± 0 . 006 (syst . ). The lepton charge asymmetry is also measured as a function of the invariant mass, rapidity, and transverse momentum of the tt¯ system. All measurements are consistent with the expectations of the standard model

Efeitos da exposição ocupacional ao mercúrio em trabalhadores de uma indústria de lâmpadas elétricas localizada em Santo Amaro, São Paulo, Brasil Effects of occupational exposure to mercury in workers at a light bulb factory in Santo Amaro, São Paulo, Brazil

O presente estudo teve como objetivo verificar a intoxicação por mercúrio metálico em trabalhadores de uma indústria de lâmpadas elétricas situada em Santo Amaro, São Paulo. Foram realizadas visitas à empresa para verificação do ambiente e das condições de trabalho, além de reuniões com os trabalhadores para uma melhor compreensão acerca do processo produtivo e de suas repercussões na saúde. Foram investigados 91 trabalhadores, dos quais 77 (84,62%) apresentaram quadro de intoxicação crônica. Entre os intoxicados, foram detectadas alterações nos testes neuropsicológicos em 76 (98,70%), alterações neurológicas em 69 (75,82%), alterações no exame clínico em 62 (68,13%) e alterações psiquiátricas em 59 (63,96%).<br>The aim of this research was to study metallic mercury poisoning in workers at a light bulb factory in Santo Amaro, São Paulo (Brazil). Visits were made to the factory to check both the work environment and the working conditions. Meetings with the workers took place in order to better understand the production process and how working conditions affect their health. Of the 91 workers investigated, 77 (84.62%) were chronically poisoned. Among chronically poisoned workers, 76 (98.70%) displayed neuropsychological alterations, 69 (75.82%) suffered from neurological impairments, 62 (68.13%) showed pathological findings under clinical examination, and 59 (63.96%) displayed psychiatric disorders

Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.

Previous randomized trials have demonstrated that rituximab maintenance (R-maintenance) can prolong time to progressive disease in patients with follicular lymphoma (FL). The phase IIIb MAXIMA study (NCT00430352) was a large prospective evaluation of R-maintenance in a daily care setting. The primary objective was safety. Secondary objectives included progression-free survival, overall survival, time to next lymphoma treatment, and partial response (PR) to complete response/unconfirmed (CR/CRu) conversion rate. Patients (n = 545) with first-line or relapsed FL who responded to 8 cycles of rituximab-based induction received R-maintenance every 2 months for 2 years. At study entry, 380 patients had CR or CRu, and 165 had PR. The median age was 57.0 years. The most common non-hematologic adverse events (AEs, excluding infusion-related reactions) were cough (9.9 % of patients), fatigue (7.5 %), nasopharyngitis (7.1 %), back pain (6.5 %), diarrhea (6.9 %), arthralgia (6.0 %), headache and hypertension (5.2 % each), and pyrexia (5.1 %). The majority of AEs were grade 1 or 2. Grade 3, 4, and 5 infections occurred in 21 (3.9 %), 2 (0.4 %), and 1 (0.2 %) patient, respectively. Fifty-one hematologic AEs occurred in 6.6 % (n = 35) of patients. Grade 3/4 prolonged neutropenia and hypogammaglobulinemia occurred in 13 (2.4 %) and 5 (0.9 %) patients, respectively. All cases of prolonged neutropenia or hypogammaglobulinemia were manageable and resolved. Fast infusion did not alter the safety profile. Efficacy was comparable with results from previous trials. R-maintenance is safe in a daily care setting for patients with first-line or relapsed FL